Introduction

　　The urology surgery department was established in 1989. It is a key clinical specialty in Guangdong Province, a key medical discipline in Shenzhen, and hosts international collaborative research on bladder cancer. It is also the South China branch of the National Urological Male Reproductive Tumor Research Center, a vice-chair unit of the Guangdong Urological Society, the chairman unit of the Shenzhen Urological Society, and the Clinical Quality Control Center for Urology in Shenzhen. The department has developed into a diagnostic and treatment center for urological diseases, focusing on urological tumors, stones, and minimally invasive techniques, with special expertise in prostate and adrenal gland diseases.

　　Specialty Features

　　The urology surgery department currently has four outpatient consultation rooms, offering sub-specialty clinics in urological tumors, urolithiasis, prostate, and male diseases. The department also has seven auxiliary functional rooms, including an extracorporeal shock wave lithotripsy center and a urodynamics room, as well as an independent outpatient surgical room. The inpatient area covers 2,000 square meters with 60 beds, and the hospital implements the “One Bed” policy, expanding the ward capacity.

　　The department is equipped with integrated operating rooms, a Da Vinci robot, 4K high-definition laparoscopic equipment, urological examination beds, dual-probe 3D extracorporeal shockwave lithotripter, physical vibration stone removal bed, various laser devices, EMS lithotripter system, prostate enucleation and resection scopes, flexible ureteroscopy, nephroscopy, bladder electronic soft scopes, infrared stone analyzers, biofeedback instruments, and urodynamics equipment. The department has multiple sub-specialty areas, including urological tumors, urolithiasis, prostate and male diseases, adrenal gland surgery, urethral repair and reconstruction, and pediatric and female urology.

　　The department excels in performing robot-assisted laparoscopic surgeries, including partial nephrectomy, radical nephrectomy, pyeloplasty, full-length nephroureterectomy, radical cystectomy, and radical prostatectomy. Other procedures include transurethral resection of bladder tumors, prostate resection/laser resection, stone removal via flexible (hard) ureteroscopy, percutaneous nephrolithotomy, bladder stone removal, and multi-scope treatment for stones. Difficult surgeries such as tension-free sling urethral suspension for stress urinary incontinence and various urethroplasty surgeries are also routinely performed. The department has a standardized MDT (multidisciplinary team) for the diagnosis and treatment of urological tumors, providing precision treatment plans for patients with urological cancers.

　　The annual outpatient volume exceeds 50,000 visits, with over 1,000 outpatient surgeries performed. The department admits approximately 4,000 patients annually and performs around 3,000 surgeries, of which over 85% are classified as high-level (3rd and 4th grade) surgeries. Minimally invasive and natural orifice surgeries account for over 99% of the procedures.